TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Lovisenberg Sykehusapotek AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
6,458
|
7,050
|
7,760 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-177
|
2
|
88 |
| Total assets |
2,267
|
1,941
|
2,104 |
| Current assets |
2,096
|
1,706
|
1,809 |
| Current liabilities |
1,589
|
1,044
|
1,136 |
| Equity capital |
679
|
898
|
968 |
| - share capital |
9
|
9
|
10 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
30.0%
|
46.3%
|
46.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.7%
|
0.0%
|
1.1% |
| Return on assets (ROA) |
-7.8%
|
0.1%
|
4.2% |
| Current ratio |
131.9%
|
163.4%
|
159.2% |
| Return on equity (ROE) |
-26.1%
|
0.2%
|
9.1% |
| Change turnover |
-145
|
-302
|
1,217 |
| Change turnover % |
-2%
|
-4%
|
19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.